Cytek Biosciences Inc (CTKB)

$3.90 -0.06 (-1.52%)
Market Cap 501.26M
Revenue (ttm) 200.45M
Net Income (ttm) -6.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3.00%
Debt to Equity Ratio 0.00
Volume 735,700
Avg Vol 1,039,302
Day's Range N/A - N/A
Shares Out 127.22M
Stochastic %K 49%
Beta 1.36
Analysts Sell
Price Target $4.70

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; g...

Industry: Medical Devices
Sector: Healthcare
Phone: 877 922 9835
Address:
47215 Lakeview Boulevard, Fremont, United States
khmerxbxboi
khmerxbxboi Sep. 15 at 4:50 PM
$CTKB = 100% run soon ...
0 · Reply
fibjoey
fibjoey Sep. 15 at 7:41 AM
$CTKB Resilient cash flows expected; monitor pricing power and competition
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 8 at 7:58 PM
$CTKB + $HE = Sleeper ...
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 8 at 2:27 PM
$CTKB = $10+
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 4 at 4:35 PM
$CTKB = $10+ soon!
0 · Reply
CompoundSigma
CompoundSigma Aug. 23 at 10:27 AM
$CTKB Cytek Biosciences Inc is facing flow cytometry competition and biotech funding environment
0 · Reply
DARKP00L
DARKP00L Aug. 21 at 5:01 PM
$CTKB this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
khmerxbxboi
khmerxbxboi Aug. 7 at 7:49 PM
$CTKB = $8+ soon ...
0 · Reply
d_risk
d_risk Aug. 7 at 1:47 AM
$CTKB - Cytek Biosciences Inc. Common Stock - 10Q - Updated Risk Factors CTKB’s 10-Q risk factors in 2025 show expanded detail on international operations, global trade tensions, FDA regulatory challenges, intensified competition, funding volatility, IP and data privacy risks, manufacturing and supply chain vulnerabilities, internal control weaknesses, and anti-takeover provisions, with no new risk categories introduced. #Biotechnology #DataPrivacy #SupplyChainRisk #GlobalTrade #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/CTKB/10-Q/2025-08-06
0 · Reply
khmerxbxboi
khmerxbxboi Jul. 23 at 6:49 PM
$CTKB = back to $7+ soon my friends ...
0 · Reply
Latest News on CTKB
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Sep 10, 2025, 5:00 PM EDT - 6 days ago

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 12:57 PM EDT - 6 days ago

Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cytek Biosciences to Participate in Upcoming Investor Conferences

Aug 12, 2025, 4:05 PM EDT - 5 weeks ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:25 AM EDT - 5 weeks ago

Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 5 weeks ago

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 29, 2025, 5:00 PM EDT - 3 months ago

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 3 months ago

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

May 11, 2025, 8:30 PM EDT - 4 months ago

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

Cytek Biosciences Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 4 months ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

May 5, 2025, 8:14 AM EDT - 4 months ago

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 29, 2025, 5:00 PM EDT - 5 months ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Apr 28, 2025, 8:15 AM EDT - 5 months ago

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 5 months ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Mar 18, 2025, 5:00 PM EDT - 6 months ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 9:49 AM EST - 7 months ago

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 27, 2025, 4:05 PM EST - 7 months ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 4:05 PM EST - 7 months ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Jan 9, 2025, 9:30 AM EST - 8 months ago

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 8:00 AM EST - 9 months ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Dec 30, 2024, 8:00 AM EST - 9 months ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 10 months ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Nov 19, 2024, 5:00 PM EST - 10 months ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Nov 7, 2024, 5:00 PM EST - 11 months ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 8:26 PM EST - 11 months ago

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Sep 18, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Sep 12, 2024, 3:20 PM EDT - 1 year ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Aug 21, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 4:25 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

May 30, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

May 28, 2024, 5:30 PM EDT - 1 year ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

Lab Instrument Industry Update - New Commercial Entrants

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO DHR LAB MASS OMIC QGEN

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

May 20, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

May 12, 2024, 3:24 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

Cytek Biosciences Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences Reports First Quarter 2024 Financial Results

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Apr 30, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 29, 2024, 9:00 AM EDT - 1 year ago

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 20, 2024, 4:33 AM EDT - 1 year ago

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Cytek® Biosciences Names William McCombe Chief Financial Officer

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cytek® Biosciences Names William McCombe Chief Financial Officer

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Mar 7, 2024, 5:30 PM EST - 1 year ago

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 7:24 PM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

Feb 28, 2024, 5:05 PM EST - 1 year ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

Jan 17, 2024, 5:30 PM EST - 1 year ago

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

Jan 8, 2024, 9:00 AM EST - 1 year ago

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 4:05 PM EST - 1 year ago

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

Dec 21, 2023, 9:00 AM EST - 1 year ago

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

Why these stocks could lose money even if the market gains

Dec 1, 2023, 7:10 AM EST - 1 year ago

Why these stocks could lose money even if the market gains

AHCO APPS CLFD DDD ENPH HRMY LUMN

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 4:05 PM EST - 2 years ago

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 10:56 AM EST - 2 years ago

Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript

khmerxbxboi
khmerxbxboi Sep. 15 at 4:50 PM
$CTKB = 100% run soon ...
0 · Reply
fibjoey
fibjoey Sep. 15 at 7:41 AM
$CTKB Resilient cash flows expected; monitor pricing power and competition
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 8 at 7:58 PM
$CTKB + $HE = Sleeper ...
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 8 at 2:27 PM
$CTKB = $10+
0 · Reply
khmerxbxboi
khmerxbxboi Sep. 4 at 4:35 PM
$CTKB = $10+ soon!
0 · Reply
CompoundSigma
CompoundSigma Aug. 23 at 10:27 AM
$CTKB Cytek Biosciences Inc is facing flow cytometry competition and biotech funding environment
0 · Reply
DARKP00L
DARKP00L Aug. 21 at 5:01 PM
$CTKB this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
khmerxbxboi
khmerxbxboi Aug. 7 at 7:49 PM
$CTKB = $8+ soon ...
0 · Reply
d_risk
d_risk Aug. 7 at 1:47 AM
$CTKB - Cytek Biosciences Inc. Common Stock - 10Q - Updated Risk Factors CTKB’s 10-Q risk factors in 2025 show expanded detail on international operations, global trade tensions, FDA regulatory challenges, intensified competition, funding volatility, IP and data privacy risks, manufacturing and supply chain vulnerabilities, internal control weaknesses, and anti-takeover provisions, with no new risk categories introduced. #Biotechnology #DataPrivacy #SupplyChainRisk #GlobalTrade #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/CTKB/10-Q/2025-08-06
0 · Reply
khmerxbxboi
khmerxbxboi Jul. 23 at 6:49 PM
$CTKB = back to $7+ soon my friends ...
0 · Reply
TheKrunchSwings
TheKrunchSwings Jul. 23 at 1:24 PM
$RCKT $ARDX $DH $CTKB $IOVA I FOUND IT WELL!!!
0 · Reply
WrappedLunatic
WrappedLunatic Jul. 18 at 4:55 PM
$CTKB ouch
1 · Reply
MGeronimo
MGeronimo Jun. 27 at 9:52 PM
$CTKB IN AT 3.55
0 · Reply
khmerxbxboi
khmerxbxboi Jun. 27 at 2:58 AM
$CTKB = 100%+ run soon ...
0 · Reply
RunnerSignals
RunnerSignals Jun. 25 at 8:21 PM
comeback kings in action! $CTKB $CDTX $IRWD $UEC $MXCT hit lows but closed strong, proving every dip can spark a big bounce
0 · Reply
khmerxbxboi
khmerxbxboi Jun. 24 at 4:04 PM
$CTKB = will be bext of $NKTR
0 · Reply
ribockski
ribockski Jun. 15 at 6:11 AM
$CNSP $CTKB $CRNX $NVDA
0 · Reply
khmerxbxboi
khmerxbxboi Jun. 12 at 10:01 PM
$CTKB = $7+ soon !
0 · Reply
TheKrunchSwings
TheKrunchSwings Jun. 11 at 5:14 PM
$RCKT $ARDX $DH $IOVA $CTKB - all positions are closed.. We banked!!! On to the next!!
0 · Reply
khmerxbxboi
khmerxbxboi Jun. 9 at 3:50 PM
$CTKB = $8+ !!!
0 · Reply
Winning_calls
Winning_calls Jun. 9 at 1:39 PM
$CTKB 🤞😉
0 · Reply
TheKrunchSwings
TheKrunchSwings Jun. 9 at 1:37 PM
$IOVA $CTKB $ARDX $CRVO they all flew.. team is happy they banked. Congrats..
0 · Reply